NL7107529A - - Google Patents
Info
- Publication number
- NL7107529A NL7107529A NL7107529A NL7107529A NL7107529A NL 7107529 A NL7107529 A NL 7107529A NL 7107529 A NL7107529 A NL 7107529A NL 7107529 A NL7107529 A NL 7107529A NL 7107529 A NL7107529 A NL 7107529A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/30—Extraction; Separation; Purification by precipitation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE763270A SE348942B (cg-RX-API-DMAC7.html) | 1970-06-02 | 1970-06-02 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NL7107529A true NL7107529A (cg-RX-API-DMAC7.html) | 1971-12-06 |
| NL177599B NL177599B (nl) | 1985-05-17 |
| NL177599C NL177599C (nl) | 1985-10-16 |
Family
ID=20271889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL7107529A NL177599C (nl) | 1970-06-02 | 1971-06-01 | Werkwijze voor het winnen en zuiveren van immunoglobuline g. |
Country Status (8)
| Country | Link |
|---|---|
| AT (1) | AT309678B (cg-RX-API-DMAC7.html) |
| CA (1) | CA960964A (cg-RX-API-DMAC7.html) |
| CH (1) | CH572745A5 (cg-RX-API-DMAC7.html) |
| DE (1) | DE2127159C2 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2100716B1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB1344340A (cg-RX-API-DMAC7.html) |
| NL (1) | NL177599C (cg-RX-API-DMAC7.html) |
| SE (1) | SE348942B (cg-RX-API-DMAC7.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE389596B (sv) * | 1974-06-14 | 1976-11-15 | P G S Lindroos | Saett att ur en vaetska innehallande blodsubstanser separera jaernfoereningar fran globin |
| DE2500076C3 (de) * | 1975-01-02 | 1982-11-18 | SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld | Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen |
| US4124576A (en) * | 1976-12-03 | 1978-11-07 | Coval M L | Method of producing intravenously injectable gamma globulin |
| AT359641B (de) * | 1978-09-19 | 1980-11-25 | Immuno Ag | Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates |
| US4315851A (en) | 1978-12-29 | 1982-02-16 | Kureha Kagaku Kogyo Kabushiki Kaisha | Pharmaceutical composition having antitumor activity |
| WO2010082894A1 (en) * | 2009-01-13 | 2010-07-22 | Ge Healthcare Bio-Sciences Ab | Precipitation of biomolecules with negatively charged polymers |
| SG176256A1 (en) | 2009-05-27 | 2012-01-30 | Baxter Int | A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use |
| IT1397061B1 (it) * | 2009-12-28 | 2012-12-28 | Kedrion Spa | Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale. |
| US8796430B2 (en) | 2010-05-26 | 2014-08-05 | Baxter International Inc. | Method to produce an immunoglobulin preparation with improved yield |
| WO2011150284A2 (en) | 2010-05-26 | 2011-12-01 | Baxter International Inc. | Removal of serine proteases by treatment with finely divided silicon dioxide |
| AU2010202125B1 (en) | 2010-05-26 | 2010-09-02 | Takeda Pharmaceutical Company Limited | A method to produce an immunoglobulin preparation with improved yield |
| EP2748193B1 (en) | 2011-08-26 | 2017-02-01 | Baxalta GmbH | Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition |
| TWI629283B (zh) | 2012-02-23 | 2018-07-11 | 巴克斯歐塔公司 | 來自血漿中的免疫球蛋白之ｉ-ｉｖ-１部分沉澱 |
| US8986670B2 (en) | 2012-02-29 | 2015-03-24 | Baxter International Inc. | IgG stimulated remyelination of peripheral nerves |
| JP6379113B2 (ja) | 2013-02-26 | 2018-08-22 | バクスアルタ インコーポレイテッド | 免疫グロブリンｇの鼻腔内投与による中枢神経系障害の治療 |
| ES2740127T3 (es) | 2013-05-06 | 2020-02-05 | Baxalta Inc | Tratamiento de subpoblaciones con enfermedad de Alzheimer con inmunoglobulina G combinada |
| MX2024010855A (es) | 2022-03-07 | 2024-09-11 | Takeda Pharmaceuticals Co | Produccion cromatografica de afinidad de productos clinicos de inmunoglobulina g (igg) humana. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL286954A (cg-RX-API-DMAC7.html) * | 1962-01-03 | |||
| BE713764A (cg-RX-API-DMAC7.html) * | 1967-05-01 | 1968-09-16 | Baxter Travenol Lab | |
| AT275038B (de) * | 1967-11-15 | 1969-10-10 | Immuno Ag | Verfahren zur Gewinnung von reinem Blutalbumin aus Hämopigmente enthaltenden Proteinlösungen |
-
1970
- 1970-06-02 SE SE763270A patent/SE348942B/xx unknown
-
1971
- 1971-05-28 GB GB1784271A patent/GB1344340A/en not_active Expired
- 1971-06-01 CH CH793671A patent/CH572745A5/xx not_active IP Right Cessation
- 1971-06-01 DE DE19712127159 patent/DE2127159C2/de not_active Expired
- 1971-06-01 CA CA114,557A patent/CA960964A/en not_active Expired
- 1971-06-01 NL NL7107529A patent/NL177599C/xx not_active IP Right Cessation
- 1971-06-01 AT AT471971A patent/AT309678B/de active
- 1971-06-02 FR FR7119993A patent/FR2100716B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NL177599C (nl) | 1985-10-16 |
| GB1344340A (en) | 1974-01-23 |
| SE348942B (cg-RX-API-DMAC7.html) | 1972-09-18 |
| FR2100716B1 (cg-RX-API-DMAC7.html) | 1975-06-06 |
| DE2127159A1 (de) | 1971-12-09 |
| NL177599B (nl) | 1985-05-17 |
| FR2100716A1 (cg-RX-API-DMAC7.html) | 1972-03-24 |
| CH572745A5 (cg-RX-API-DMAC7.html) | 1976-02-27 |
| DE2127159C2 (de) | 1981-12-24 |
| CA960964A (en) | 1975-01-14 |
| AT309678B (de) | 1973-08-27 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| V4 | Lapsed because of reaching the maxim lifetime of a patent |